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Of the 176 randomly selected, commensal, gram-negative bacteria isolated from healthy children with low
exposure to antibiotics, 138 (78%) carried one or more of the seven macrolide resistance genes tested in this
study. These isolates included 79 (91%) isolates from the oral cavity and 59 (66%) isolates from urine samples.
The mef(A) gene, coding for an efflux protein, was found in 73 isolates (41%) and was the most frequently
carried gene. The mef(A) gene could be transferred from the donors into a gram-positive E. faecalis recipient
and a gram-negative Escherichia coli recipient. The erm(B) gene transferred and was maintained in the E. coli
transconjugants but was found in 0 to 100% of the E. faecalis transconjugants tested, while the other five genes
could be transferred only into the E. coli recipient. The individual macrolide resistance genes were identified
in 3 to 12 new genera. Eight (10%) of the oral isolates and 30 (34%) of the urine isolates for which the MICs
were 2 to >500 g of erythromycin per ml did not hybridize with any of the seven genes and may carry novel
macrolide resistance genes.
The use of macrolide and related antibiotics (ketolides, ox-
azolidinones, streptogramins, and lincosamide) has increased
dramatically over the last 15 years. A number of different
mechanisms of macrolide resistance have been reported for
gram-negative bacteria. These mechanisms include two ester-
ase genes [ere(A) and ere(B)] found in Escherichia coli and
Enterobacter, Klebsiella, Citrobacter, and Proteus species (1) and
more recently, in Providencia stuartii, Pseudomonas species,
and Vibrio cholerae (5, 17, 22). These mechanisms also include
three phosphorylase genes [mph(A), mph(B), and mph(D)]
found in E. coli (14, 15) and Pseudomonas (12) and one rRNA
methylase gene [erm(B)] previously found in E. coli and Acti-
nobacillus, Klebsiella, Neisseria, and Wolinella species (1, 4,
18–21). The strains described above were principally clinical
isolates from hospital settings and/or from patients with clini-
cal disease (17, 18, 20, 21), with members of the family Enter-
obacteriaceae and Pseudomonas species primarily isolated from
France and Japan (1, 5, 11, 12, 14, 15). In contrast, relatively
little is known about the presence of these six macrolide resis-
tance genes in gram-negative bacteria from healthy individuals.
Recently, Cousin et al. found the efflux gene mef(A) in
Neisseria gonorrhoeae and Acinetobacter junii (3, 7). This gene
has been transferred, by conjugation in the laboratory, into a
variety of gram-negative species, including Eikenella corrodens,
Haemophilus influenzae, Kingella denitrificans, Moraxella ca-
tarrhalis, commensal Neisseria, and Neisseria meningitidis recip-
ients using both gram-negative and gram-positive donors (7).
These results suggested that the mef(A) gene may also be
widespread among gram-negative species, so the mef(A) gene
was included in the study of a group of randomly selected,
commensal, gram-negative bacterial strains from oral and
urine samples, collected from healthy children with low expo-
sure to antibiotics from Lisbon, Portugal, for the presence of
these seven acquired genes coding for macrolide resistance.
MATERIALS AND METHODS
Population and bacterial strains. A total of 176 randomly chosen, commensal,
gram-negative bacterial strains were isolated from oral and urine samples col-
lected from healthy children in Lisbon, Portugal, who were participating in a
randomized study designed to assess the safety of low-level mercury exposure
from dental amalgam restorations. Children were 8 to 11 years of age during the
recruitment period of February 1997 through April 1998, while isolates were
from cultures obtained between December 1997 and March 1999 (Table 1).
From the records, we found that during the collection period, five or six children
per year received some type of medication from the doctors and included both
antibiotics and nonantibiotic drugs. The bacteria represented 13 different genera
(Table 1) and included 87 isolates from the oral cavity and 89 isolates from urine.
The isolates were identified using CHROMagar orientation medium (DRG
International, Inc., Mountainside, N.J.), standard biochemicals (10), and API
kits according to the manufacturer’s instructions (Biomerieux, Hazelwood, Mo.).
Media. Luria-Bertani (LB) agar (Difco Laboratories, Division of Becton Dick-
inson & Co., Sparks, Md.) unsupplemented or supplemented with 25 g of
erythromycin per ml was used to grow the clinical isolates. The E. coli strain
HB101 and Enterococcus faecalis JH2-2 recipients were grown without antibiotic.
All isolates were incubated at 36.5°C.
Agar dilution susceptibility testing. Erythromycin MICs were determined by
the agar dilution method as described by the National Committee of Clinical
Laboratory Standards (13) for all isolates. MIC breakpoints are not available for
macrolides for most gram-negative species. We did not attempt to distinguish
resistance from susceptibility and used MICs.
Detection of acquired genes. Isolates were initially screened by DNA-DNA
hybridization of whole-cell dot blots and/or DNA dot blots as previously de-
scribed (2–4, 6–9, 18). PCR was performed on selected isolates to confirm the
presence of the various macrolide genes (3, 4, 8). Oligonucleotide probes for
PCR and DNA-DNA hybridization are listed in Table 2. Radiolabeled probes
were used as previously described (8).
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TABLE 1. Distribution of macrolide resistance genes found in gram-negative isolates from the oral cavity and urine samples
Genus
Oral isolates Urine isolates
No. of isolates Gene(s) carrieda No. of isolates Gene(s) carried
Acinetobacter 3 1 mef(A)
1 ere(A)
1 ere(B), erm(B)
Citrobacter 4 1 ere(A) 1 1 mef(A)
1 mef(A), erm(B)
1 mef(A), mph(A)
1 mef(A), ere(A), ere(B), mph(A)
Enterobacter 6 2 mef(A)
1 erm(B)
1 ere(B)
1 mef(A), ere(B), mph(A)
1 mef(A), ere(A), ere(B), mph(A), mph(B)
Escherichia 7 3 mef(A) 19 2 mef(A)
2 erm(B) 12 mph(A)
1 ere(a) 1 mph(B)
1 mph(A), mph(B), mph (D) 1 mph(A), mph(B)
1 mef(A), mph(B)
1 mef(A), mph(D)
1 mef(A), ere(B), mph(A), mph(B) mph(D)
Klebsiella 19 5 mef(A) 6 1 mef(A)
4 ere(A) 2 erm(B)
2 erm(B) 1 mph(A)
2 mef(A), erm(B) 2 mph(A), mph(B), mph(D)
1 mef(A), mph(A)
1 ere(A), ere(B), mph(D)
1 mef(A), ere(A), mph(A), mph(B)
1 mef(A), ere(A), mph(A)
1 mef(A), ere(B), mph(D)
1 mef(A), ere(A), ere(B), mph(A), mph(D), erm(B)
Morganella 1 1 mef(A)
Pantoeae 1 1 mef(A), ere(A), mph(A), mph(D), erm(B)
Providencia 1 1 mef(A)
Pseudomonas 31 14 mef(A) 19 3 erm(B)
3 ere(A) 4 mef(A)
2 mef(A), ere(A) 1 mph(D)
1 mef(A), erm(B) 2 mph(A)
1 mef(A), mph(B) 1 mef(A), mph(B)
1 mph(A), mph(B), mph(D) 3 mef(A), erm(B)
2 erm(B), ere(A), ere(B) 1 mph(A), mph(B)
1 mef(A), ere(A), mph(D) 1 mef(A), ere(A), ere(B), mph(A), mph(B), mph(D)
1 mef(A), ere(A), mph(D), erm(B) 2 mef(A), ere(B), mph(A), mph(B), mph(D)
1 mef(A), ere(B), mph(A), mph(D) 1 mef(A), ere(B), mph(A), mph(B), mph(D), erm(B)
2 ere(A), ere(B), mph(B), mph(D)
1 ere(A), mph(A), mph(B), mph(D)
1 ere(A), mph(A), mph(B), erm(B)
Proteus 13 1 mef(A)
1 erm(B)
7 mph(D)
1 mph(A), mph(D)
2 mph(A), mph(B)
1 mef(A), erm(B)
Ralstonia 1 1 mef(A), mph(A)
Serratia 3 1 mef(A), erm(B)
1 mef(A),
1 mef(A), ere(A), ere(B)
Stenotrophomonas 3 1 mph(A)
1 mef(A), ere(A), mph(A)
1 mef(A), mph(A), mph(D)
Total 79 59
a Gene(s) carried on the isolates. The number is the number of isolates carrying the gene(s) shown.
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Mating. Fifteen donors and one transconjugant donor were selected to be
mated with erythromycin-susceptible E. faecalis JH2-2 and/or erythromycin-sus-
ceptible E. coli HB101. The erythromycin MIC for E. faecalis JH2-2 was 0.5
g/ml, and the erythromycin MIC for E. coli HB101 was 16 g/ml. Matings were
performed on agar plates, and transconjugants were identified as previously
described because they expressed erythromycin resistance (6–8, 18). The
transconjugants were selected with 5 g of erythromycin per ml for E. faecalis
JH2-2 and 25 to 50 g of erythromycin per ml for E. coli HB101. The presence
of acquired macrolide resistance genes in 5 to 10 of the transconjugants from
each mating pair was determined by DNA-DNA hybridization and PCR for each
of the macrolide resistance genes as previously described (2–4, 7, 8, 18). Positive
controls were used in each assay.
DNA-DNA hybridization. DNA-DNA hybridization of Southern blots, whole-
cell bacterial dot blots, whole-cell DNA dot blots, and/or PCR dot blots was
performed as previously described. DNA was hybridized with the appropriate
32P-labeled probe as previously described (2).
PCR. Seven different PCRs were performed to detect each of the seven genes
separately. PCR assays for the erm(B) and mef(A) genes were conducted as
previously described (2–4, 7, 8, 17). For the other five genes, new assays were
developed using 2 U of Taq polymerase (Perkin-Elmer Cetus, Norwalk, Conn.),
200 M (each) deoxynucleotide triphosphates, 1 PCR buffer (1.5 mM MgCl2),
100 ng of each primer, and 200 ng of whole DNA as the template. To detect
the ere(A) and ere(B) genes, PCR was performed as follows: an initial denatur-
ation step (96°C for 3 min); followed by 35 cycles of PCR, with 1 cycle consisting
of denaturation (96°C for 30 s), annealing (56°C for 1 min), and elongation (72°C
for 2 min). For the mph(A), mph(B), and mph(D) genes, the initial denaturation,
denaturation, and elongation times and temperatures were the same, but an-
nealing was done at 57°C for 1 min. For all assays, the final step was 72°C for 10
min, followed by incubation at 4°C. Positive and negative controls were included
in each run. The PCR products were visualized on a 1.5% agarose gel as
previously described. Southern blots and/or dot blots of the PCR products were
hybridized using an internal 32P-labeled probe to verify the PCR products as
previously described (2–4, 7, 8, 18).
RESULTS
Macrolide susceptibility and detection of the seven macro-
lide resistance genes. Of the 13 genera, four were found in
both the oral and urine samples (Table 1). The erythromycin
MICs for the isolates ranged from 2 to 500 g/ml; the eryth-
romycin MICs for most of the isolates were 64 g/ml. The
MICs for isolates within a species varied, with Pseudomonas
(MICs, 4 to 500 g/ml) and Klebsiella (MICs, 16 to 500
g/ml) having the widest range (data not shown). Of the 176
isolates, 138 (78%) isolates, including 79 (91%) isolates from
the oral cavity and 59 (66%) isolates from urine samples,
hybridized with one or more of the seven gene probes used
(Table 1). Forty-four (56%) oral and 40 (68%) urine isolates
carried one of the seven macrolide genes, while 35 (44%) oral
and 19 (32%) urine isolates carried two or more of the seven
macrolide genes examined. The mef(A) gene was found in 74
(54%) of the isolates, including 51 (65%) of the oral isolates
and 22 (37%) of the urine isolates and was the most common
gene found in this population. The mph(A) gene was the sec-
ond most commonly found gene; it was found in 45 (33%)
isolates, which included 18 (23%) oral isolates and 27 (46%)
urine isolates.
The other five genes, erm(B), ere(A), ere(B), mph(B), and
mph(D), were found in 14 to 22% of the total isolates (Table
1). The distribution of the erm(B) gene was similar in the
isolates from the oral cavity (22%) and urine samples (19%),
while the ere(A) gene was found more commonly in the oral
isolates (38%) than in the urine isolates (1%). In contrast, the
mph(B), mph(D), and/or ere(B) genes were more common in
the urine isolates than in the oral isolates (Table 1).
The mef(A) gene has previously been found in A. junii (7),
but this is the first report of this gene in the other 12 genera
examined (Table 3). The mph(A) gene was identified in eight
new genera, the mph(D) gene was identified in seven new
genera, the erm(B) gene was found in six new genera, the
ere(B) gene was found in five new genera, and the ere(A) gene
TABLE 2. Primers used in this study
Gene Primer Sequence (533) Reference(s)
mef(A) mefF TGT GCA TAT TTC TAT TAC G This study
mefR CCA ATT GGC ATA GCA AG This study
mefI GCT GTG CAA TAA TGG GGC This study
ere(A) ereAF GCC GGT GCT CAT GAA CTT GAG This study
ereAR CGA CTC TAT TCG ATC AGAGGC This study
ereAI TCA CTG GCT AGA GCT AGT CTT This study
ere(B) ereBF GCC TTG AAG CTA TGG CTC C This study
ereBR GGC CCA TTG GTA GGC AAC This study
ereBI TTG GAG ATA CCC GAG TTG TAG This study
erm(B) ermBF GAA AAG GTA CTC AAC CAA ATA 7, 8
ermBR AGT AAC GGT ACT TAA ATT GTT TAC 7, 8
ermBI AGC CAT GCG TCT GAC ATC TAT 7, 8
mph(A) mphAF GTG AGG AGG AGC TTC GCG AG This study
mphAR TGC CGC AGG ACT CGG AGG TC This study
mphAI GAT ACC TCC CAA CTG TAC GCA This study
mph(B) mphBF TTA AAC AAG TAA TCG AGA TAG C This study
mphBR CCT TGT ACT TCC AAT GCT T G This study
mphBI GCG TAT GGA TGC AGT AAG AGC This study
mph(D) mphDF GTG TTC TTG CTT GGC TCG TAA This study
mphDR ATC TGG TCG GGG TTG ATA A This study
mphDI GCG GAT CTC CTC CCA GAG TG This study
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and the mph(B) genes were found in three new genera (Table
3).
Eight isolates (10%) from the oral cavity (two Acinetobacter
isolates, three Enterobacter isolates, two Klebsiella isolates, and
one Pseudomonas isolate) were negative for all seven macro-
lide resistance genes. Thirty (34%) isolates from urine samples
(one Acinetobacter isolate, eight Escherichia isolates, five Kleb-
siella isolates, four Morganella isolates, four Proteus isolates,
and eight Pseudomonas isolates) were negative for all seven
macrolide resistance genes. These isolates, representing seven
genera, did not hybridize with any of the gene probes used
[ere(A), ere(B), mph(A), mph(B), mph(D), mef(A), or erm(B)].
The erythromycin MICs for oral isolates ranged from 2 to 256
g/ml; the erythromycin MICs for five isolates were 64 g/
ml. The erythromycin MICs for urine isolates ranged from 2 to
500 g/ml; the erythromycin MICs for 24 isolates were 64
g/ml.
Characterization of specific isolates. Fifteen isolates from
10 genera were chosen for further characterization (Table 4).
There was no apparent correlation between MIC and the num-
ber or type of macrolide resistance gene(s) carried (Table 4).
Mating experiments were done using the 15 isolates as donors
and E. faecalis and/or E. coli as the recipient(s) (Table 4). A.
junii 329 has been included in Table 4 for comparison (7). The
presence of acquired macrolide resistance genes were deter-
mined in 5 to 10 transconjugants, from each mating pair. The
mef(A) gene was transferred to the E. faecalis recipient at
frequencies from 105 to 109/recipient. The mef(A) gene also
transferred to the E. coli recipient at frequencies from 105 to
109/recipient. One transconjugant, E. coli 11 donor (HB101
transconjugant) carrying the mef(A) gene, was used as a donor
and mated with the E. faecalis recipient. Transconjugants from
this mating were detected at low frequencies, indicating that
the HB101 transconjugant maintained its ability to retransfer
the mef(A) gene (Table 4).
In six of the gram-negative donors, both the erm(B) and
mef(A) genes were present, and the overall transfer of macro-
lide resistance genes varied from 105 to 109/recipient (Table
4). In five of the matings, the mef(A) gene was transferred and
detected in the E. faecalis transconjugants, while the erm(B)
gene was detected in 25 to 100% of the E. faecalis transcon-
jugants. With the Klebsiella oxytoca 561 donor, the erm(B) gene
was not detected in the E. faecalis transconjugants even after
multiple mating experiments (Table 4). The esterase and phos-
phorylase genes were not detected in the E. faecalis transcon-
jugants from any of the matings.
Seven of the donors carried macrolide resistance genes in
addition to the erm(B) and/or mef(A) genes, with two carrying
a total of six different macrolide resistance genes and one
carrying a total of five different macrolide resistance genes.
These donors were mated with the E. coli recipient, and the
frequency of transfer ranged from 105 to 109 per recipient
(Table 4). All the macrolide resistance genes carried in the
donors were identified in the E. coli transconjugants tested.
DISCUSSION
In this study, 78% of the randomly selected, commensal,
gram-negative bacteria from a healthy population with low
exposure to antibiotics were found to carry one or more of the
seven macrolide resistance genes tested. Unfortunately, there
is little previously published data from other countries avail-
able for comparison of data, because most studies have focused
on macrolide resistance in pathogenic bacteria from clinical
settings and/or diseased hosts (1, 3, 4, 6, 7, 9, 11, 12, 14–18, 22).
However, we can compare these results with those of an earlier
study by Luna et al. (8) on 615 randomly selected, commensal,
gram-positive isolates from the same group of Lisbon children
as the current study over the same time period. In that study,
222 (36%) isolates carried one or more of four different rRNA
methylases and mef(A) efflux gene, which is less than 50% of
the rate we found in the current gram-negative study, indicat-
ing that in this Lisbon population, acquisition of macrolide
resistance genes is more prevalent in commensal, gram-nega-
tive isolates than in commensal, gram-positive isolates. The
mef(A) and erm(B) genes were examined in both groups of
bacteria, and the percentage in each population was compared.
For the mef(A) and erm(B) genes, 9 and 60% were found in
the gram-positive bacteria, respectively, while 54 and 19%
were found in the gram-negative isolates, respectively.
TABLE 3. Macrolide resistance genes found in new genera
Type of gene Gene No. of new genera New genera
rRNA methylase erm(B) 6 Acinetobacter, Enterobacter, Pantoeae, Proteus,
Pseudomonas, Serratia
Efflux (major facilitator) mef(A) 12 Citrobacter, Enterobacter, Escherichia, Klebsiella,
Morganella, Pantoeae, Proteus, Providencia,
Pseudomonas, Ralstonia, Serratia,
Stenotrophomonas
Esterase ere(A) 3 Pantoeae, Pseudomonas, Stenotrophomonas
ere(B) 5 Acinetobacter, Citrobacter, Enterobacter,
Pseudomonas, Stenotrophomonas
Phosphorylase mph(A) 8 Citrobacter, Enterobacter, Klebsiella, Pantoeae,
Pseudomonas, Proteus, Serratia,
Stenotrophomonas
mph(B) 3 Enterobacter, Pseudomonas, Proteus
mph(D) 7 Escherichia, Klebsiella, Pantoeae, Proteus,
Pseudomonas, Serratia, Stenotrophomonas
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The distribution of the seven macrolide resistance genes in
the gram-negative bacteria varied by genus and location. How-
ever, with only four genera found in both the oral cavity and
urine samples, it was not surprising that these seven different
genes were found in different percentages of the oral and urine
isolates. The mef(A) gene was identified in at least one isolate
from each of the 13 genera examined, while the mph(A) gene
was the second most commonly found gene overall (Table 1).
Each of the seven macrolide resistance genes was identified in
a number of new genera, suggesting that the host range of
these genes is larger than the literature has suggested (Table
3).
We had 8 isolates from the oral cavity and 30 isolates from
urine samples that did not carry any of the known genes.
The erythromycin MICs for the majority of the isolates were
64 g/ml. Susceptibility to clindamycin, determined by
agar dilution, was examined for these strains. The clinda-
mycin MICs for most of the isolates was the same or plus or
minus up to eightfold of their erythromycin MICs (data not
shown). Other erm genes have been identified in gram-
negative Actinobacillus spp. (21), Neisseria spp. (18), and a
variety of anaerobic gram-negative genera (2, 19–21). Thus,
it is possible that some of the other known rRNA methylase
genes are present in the 38 gram-negative strains found in
this study. We are currently testing these isolates for the
presence of the erm(A), erm(C), erm(F), erm(G), and
erm(Q) genes, which are the most widespread genes found
other than the erm(B) gene. Three interesting isolates were
identified. For one Acinetobacter isolate, the erythromycin
MIC was 16 g/ml, and the clindamycin MIC was 500
g/ml. For one E. coli isolate, the erythromycin MIC was 64
g/ml, and the clindamycin MIC was 500 g/ml. For one
Pseudomonas isolate, the erythromycin MIC was 8 g/ml,
and the clindamycin MIC was 500 g/ml. These three iso-
lates may carry a lincosamide resistance gene. These isolates
and all of the nonreactive isolates will be examined for the
TABLE 4. Transfer of macrolide resistance genes
Donor
ERYa
MIC
(g/ml)
Gene(s) carried Recipient Frequencyb Gene(s) transferred
Oral isolates
Acinetobacter junii 329c 2 mef(A) E. faecalis 9.5  106 mef(A)
Citrobacter freundii 16 256 mef(A), erm(B) E. faecalis 1.6  108 mef(A), erm(B)d
Enterobacter cloacae 240 256 mef(A) E. faecalis 5.3  109 mef(A)
Escherichia coli 11 64 mef(A) E. faecalis 6.3  107 mef(A)
mef(A) E. coli 3.9  109 mef(A)
E. coli HB101 transconjugante mef(A) E. faecalis 2.0  1010 mef(A)
Klebsiella sp. 7 128 mef(A) E. faecalis 3.0  107 mef(A)
Klebsiella sp. 8 256 mef(A), erm(B) E. faecalis 2.9  108 mef(A), erm(B)f
mef(A), erm(B) E. coli 4.5  108 mef(A), erm(B)
Klebsiella sp. 9 256 mef(A), ere(B), mph(D) E. faecalis 5.1  106 mef(A)
Klebsiella sp. 106 128 mef(A) E. faecalis 2.4  108 mef(A)
K. oxytoca 561 128 mef(A), erm(B), ere(A), ere(B),
mph(A), mph(B)
E. faecalis 2.0  107 mef(A), erm(B)g
E. coli 3.8  105 mef(A), erm(B), ere(A), ere(B),
mph(A), mph(B)
Pantoeae agglomerans 323 256 mef(A), ere(A), mph(A),
mph(D), erm(B)
E. faecalis 1.3  107 mef(A), erm(B)h
E. coli 4.7  109 mef(A), erm(B), ere(A),
mph(A), mph(D)
Pseudomonas sp. 203 500 mef(A), ere(A), ere(B), mph(A),
mph(D), erm(B)
E. faecalis 4.0  108 mef(A), erm(B)i
E. coli 2.2  107 mef(A), ere(A), ere(B),
mph(A), mph(D), erm(B)
Pseudomonas sp. 333 128 mef(A), erm(B) E. faecalis 1.0  105 mef(A), erm(B)j
mef(A), erm(B) E. coli 4.0  109 mef(A), erm(B)
Pseudomonas putida 366 500 ere(A), mph(A), mph(D),
mef(A)
E. faecalis 2.5  109 mef(A)
Serratia liquefaciens 136 64 mef(A), ere(A), ere(B) E. faecalis 7.2  108 mef(A)
Urine isolates
Morganella morganii 236 500 mef(A) E. faecalis 6.7  108 mef(A)
Proteus sp. 21 500 mef(A), mph(A) E. faecalis 1.0  109 mef(A)
a ERY, erythromycin.
b Number of transconjugants per recipient.
c Data from reference 7.
d 33% of E. faecalis transconjugants carried both the mef(A) and erm(B) genes, all carried mef(A).
e Transconjugant from E. coli 11 mated with E. faecalis JH2-2 and selected on erythromycin.
f 50% of E. faecalis transconjugants carried both the mef(A) and erm(B) genes; all carried mef(A).
g No erm(B) gene was detected in the E. faecalis transconjugants with the donor K. oxytoca 561.
h 100% of the E. faecalis transconjugants carried both the mef(A) and erm(B) genes.
i 50% of the E. faecalis transconjugants carried both the mef(A) and erm(B) genes; all carried mef(A).
j 25% of the E. faecalis transconjugants carried both the mef(A) and erm(B) genes; all carried mef(A).
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presence of the lnu(A) and lnu(B) transferase genes, which
have previously been found only in Staphylococcus and En-
terococcus, respectively (19).
The mef(A) gene transferred to both the E. coli and E.
faecalis recipients, with all transconjugants receiving and main-
taining this gene. In contrast, the erm(B) gene, a gene of
gram-positive bacterial origin, transferred and was maintained
in some but not all E. faecalis transconjugants examined (Table
4). The variability in transfer and maintenance appears to be
donor specific, since the same recipient was used with each
mating. The reason for this variability is currently being exam-
ined but could be due to the location of the erm(B) gene
(plasmid versus conjugative transposon). However, all seven
genes were associated with mobile elements in most of the
donors examined and were able to conjugally transfer these
genes to unrelated recipients in the laboratory. It is also likely
that these strains would be able to conjugally transfer these
genes to unrelated bacteria in their human hosts as well.
Few studies have examined erythromycin MICs for members
of the family Enterobacteriaceae or for Pseudomonas species.
Both groups have been thought to be innately nonsusceptible
to erythromycin due to innate multidrug-resistant transporters
which confer resistance to 14-membered macrolides (16).
Clearly, more work needs to be done to determine whether the
data from this group of bacteria can be generalized to bacteria
from other geographic locations, isolates collected during dif-
ferent time periods, and populations of bacteria from humans,
animals, and the environment.
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